Michael E Berens

Title: Michael E Berens: Innovator in Genetic Research

Introduction

Michael E Berens is a prominent inventor based in Phoenix, AZ, known for his significant contributions to the field of genetic research. He holds a total of 4 patents, focusing on advancements in understanding cancer treatment through genetic signatures.

Latest Patents

One of his latest patents is titled "Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer." This invention relates to the identification of genetic signatures and expression profiles that are part of the Base Excision Repair (BER) pathway, a crucial DNA repair mechanism that modifies base lesions. In this patent, Berens provides a method for determining the responsiveness of treatment by BER inhibitors for malignant glioma. This method involves assessing the expression levels of specific genes, including a low level of expression of Apex 1, a low level of expression of Apex 2, and a high level of expression of MPG.

Career Highlights

Throughout his career, Michael E Berens has worked with notable organizations such as the Translational Genomics Research Institute and Dignity Health. His work has significantly impacted the understanding of genetic factors in cancer treatment.

Collaborations

He has collaborated with esteemed colleagues, including Shwetal V Mehta and Harshil Dineshkumar Dhruv, contributing to various research initiatives in the field of genetics.

Conclusion

Michael E Berens continues to be a vital figure in genetic research, with his innovative patents paving the way for advancements in cancer treatment. His work exemplifies the intersection of genetics and medical science, highlighting the importance of understanding genetic vulnerabilities in developing effective therapies.